These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34774739)

  • 1. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
    San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
    Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P; Kantachuvesiri S; Thammanichanond D
    Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.
    Lee H; Min JW; Kang H; Lee H; Eum SH; Park Y; Yang CW; Chung BH; Oh EJ
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
    Wen J; Basu A; Bentall A; Henderson N; Dukek B; Gandhi M; Schinstock C
    Hum Immunol; 2021 Apr; 82(4):240-246. PubMed ID: 33618904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients.
    Charnaya O; Jones J; Philogene MC; Chiang PY; Segev DL; Massie AB; Garonzik-Wang J
    Pediatr Nephrol; 2021 Dec; 36(12):3971-3979. PubMed ID: 34100108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival.
    Bekbolsynov D; Mierzejewska B; Borucka J; Liwski RS; Greenshields AL; Breidenbach J; Gehring B; Leonard-Murali S; Khuder SA; Rees M; Green RC; Stepkowski SM
    Front Immunol; 2020; 11():580752. PubMed ID: 33193383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
    Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
    J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
    Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
    Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
    HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.
    Zhang J; Liu D; Zhang C; Zhou M; Lv J; Wang H; Yang H; Fan L; Wu B; Chen J
    Ann Transl Med; 2020 Feb; 8(3):37. PubMed ID: 32154282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
    Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP
    Hum Immunol; 2022 Mar; 83(3):248-255. PubMed ID: 35101308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.